Therefore, the significant increase of HDAC1 and HDAC2 pathological hmMSC could have a stronger impact on DCM, whereas their response to SAHA could more significantly increase expression of cardiomyogenic genes than class II HDACs. This evidence concerns the gene HDAC2 and familial dilated cardiomyopathy.